Result Summary for 115496
| Protocol ID: | 115496 |
| Clinical Study ID: | OTX115496 |
| Official Title: | DEFEND-1 Long Term Follow Up: Durable-Response Therapy Evaluation for Early or New Onset Type 1 Diabetes Extension Study |
| Phase: | phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | otelixizumab |
| Trade/Product Name: | otelixizumab |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
